Who are Lexaria Bioscience Corp.'s main suppliers?

Lexaria Bioscience Corp. (LEXX) key suppliers include: LEXARIA-NICOTINE-LLC, Gelteq Limited. View the full supplier network at chainsifter.com/chain/LEXX.

Who are Lexaria Bioscience Corp.'s major customers?

Lexaria Bioscience Corp. (LEXX) key customers include: CUSTOMER, HILL-INCORPORATED, Altria Group, Inc., Altria Group, Inc., ALTRIA-VENTURES-INC and 9 more. View the full customer network at chainsifter.com/chain/LEXX.

What sector is Lexaria Bioscience Corp. in?

Lexaria Bioscience Corp. (LEXX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Lexaria Bioscience Corp. (LEXX) Supply Chain: 19 Verified Relationships

2Suppliers

14Customers

3Debt Items

15Related Chains

Source-Backed Evidence Depth

Lexaria Bioscience Corp. (LEXX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

20Total relationships

3Distinct source URLs

7High confidence

0.727Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Lexaria Bioscience Corp. Suppliers

Ticker	Name	Confidence	Evidence
LEXARIA-NICOTINE-LLC	LEXARIA-NICOTINE-LLC	80%	Lexaria Nicotine LLC, (16.667% owned by Altria Ventures Inc.) holds the exclusive rights to the use or sublicense of DehydraTECH with nicotine molecules.
GELS	Gelteq Limited	72%	Reciprocal relationship from GELS graph: Reciprocal relationship from LEXX graph: Reciprocal relationship from GELS graph: partnerships for us. Sosna is a team of life sciences experts with more than…

Lexaria Bioscience Corp. Customers

Ticker	Name	Confidence	Evidence
CUSTOMER	CUSTOMER	92%	In the six months ended February 28, 2025, the Company recognized revenue of $ 357,923 on a consolidated basis. Two customers accounted for 100 % of that total.
HILL-INCORPORATED	HILL-INCORPORATED	85%	In January 2021, Lexaria’s wholly-owned subsidiary, Lexaria CanPharm ULC sold its exclusive license rights and assigned all sublicenses for the use of DehydraTECH with non-pharmaceutical THC-related …
MO	Altria Group, Inc.	72%	ments do not include any adjustments that might be necessary if the Company is not able to continue as a going concern. F-6 Table of Contents % of Lexaria Nicotine LLC and the remaining % is owned by…
MO	Altria Group, Inc.	72%	Reciprocal relationship from MO graph: Reciprocal relationship from LEXX graph: Reciprocal relationship from MO graph: Reciprocal relationship from LEXX graph: Reciprocal relationship from MO graph: …
ALTRIA-VENTURES-INC	ALTRIA-VENTURES-INC	62%	l studies on DehydraTECH-enhanced GLP-1 and GIP drug formulations to determine if better efficacy with reduced side effects will occur utilizing the DehydraTECH patented technology. 11 Table of Conte…
AU-PTY-LTD	AU-PTY-LTD	62%	CONSOLIDATED FINANCIAL STATEMENTS February 28, 2026 (Expressed in U.S. Dollars Except Share Amounts) (Unaudited) 1. Nature of Business Lexaria Bioscience Corp. (“Lexaria”, “we”, “our” or “the Company…
BOLDT-RUNNERS-CORPORATION	BOLDT-RUNNERS-CORPORATION	62%	ive licenses: · Non-exclusive license with Hill Inc. for all product formats globally; · Non-exclusive license with Boldt Runners Corporation for oral pouch and oral mulch products in the US, South A…
CANNFECTIONS-GROUP-INC	CANNFECTIONS-GROUP-INC	62%	ive licenses: · Non-exclusive license with Hill Inc. for all product formats globally; · Non-exclusive license with Boldt Runners Corporation for oral pouch and oral mulch products in the US, South A…
DEHYDRATECH-LEXARIA-HEMP-CORP	DEHYDRATECH-LEXARIA-HEMP-CORP	62%	l studies on DehydraTECH-enhanced GLP-1 and GIP drug formulations to determine if better efficacy with reduced side effects will occur utilizing the DehydraTECH patented technology. 11 Table of Conte…
HILL-STREET-BEVERAGE-COMPANY-INC	HILL-STREET-BEVERAGE-COMPANY-INC	62%	l studies on DehydraTECH-enhanced GLP-1 and GIP drug formulations to determine if better efficacy with reduced side effects will occur utilizing the DehydraTECH patented technology. 11 Table of Conte…
LEXARIA-CANPHARM-ULC-LEXARIA-CANPHARM-HOLDING-CO	LEXARIA-CANPHARM-ULC-LEXARIA-CANPHARM-HOLDING-CO	62%	CONSOLIDATED FINANCIAL STATEMENTS February 28, 2026 (Expressed in U.S. Dollars Except Share Amounts) (Unaudited) 1. Nature of Business Lexaria Bioscience Corp. (“Lexaria”, “we”, “our” or “the Company…
LEXARIA-NUTRACEUTICAL-CORP	LEXARIA-NUTRACEUTICAL-CORP	62%	CONSOLIDATED FINANCIAL STATEMENTS February 28, 2026 (Expressed in U.S. Dollars Except Share Amounts) (Unaudited) 1. Nature of Business Lexaria Bioscience Corp. (“Lexaria”, “we”, “our” or “the Company…
PREMIER-ANTI-AGING-CO-LTD	PREMIER-ANTI-AGING-CO-LTD	62%	ive licenses: · Non-exclusive license with Hill Inc. for all product formats globally; · Non-exclusive license with Boldt Runners Corporation for oral pouch and oral mulch products in the US, South A…
PREMIER-WELLNESS-SCIENCE-CO-LTD	PREMIER-WELLNESS-SCIENCE-CO-LTD	62%	ive licenses: · Non-exclusive license with Hill Inc. for all product formats globally; · Non-exclusive license with Boldt Runners Corporation for oral pouch and oral mulch products in the US, South A…

Lexaria Bioscience Corp. Debt Obligations

Instrument	Description	Confidence	Evidence
LEXX-DEBT	Debt stack $94,386	90%	Market cache reports total debt of $94,386.
LEXX-DEBT-10659	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2017-08-31.
LEXX-DEBT-10658	Warrants outstanding: 2052140	90%	xbrl warrant detail from xbrl 2026-02-28.

Lexaria Bioscience Corp. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Lexaria Bioscience Corp..

Lexaria Bioscience Corp. Ownership

Holder	Name	Confidence	Evidence
LEXX-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 28 tracked holders.

Lexaria Bioscience Corp. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
BUD	Anheuser-Busch InBev SA/NV	100.00	2
BUDFF	Anheuser-Busch InBev SA/NV	100.00	2
PM	Philip Morris International Inc.	100.00	2
HYEX	Healthy Extracts Inc.	100.00	2
JTIUH	JTIUH	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
HCMC	Healthier Choices Management Corp.	50.00	2
TPB	Turning Point Brands, Inc.	50.00	2
UVV	Universal Corporation	50.00	2
USSTC	USSTC	50.00	2
NJOY	NJOY	50.00	2
PFGC	Performance Food Group Company	50.00	2
MO	Altria Group, Inc.	38.88	1	['customer']
GELS	Gelteq Limited	36.29	1	['supplier']
CRON	Cronos Group Inc.	14.78	2

Lexaria Bioscience Corp. Supply Chain